UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Espranor 8 mg frystorkad tablett
- Invented name part: Espranor
- Strength part: 8 mg
- Pharmaceutical dose form part: Frystorkad tablett
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Oral lyophilisate
Legal status of supply: Medicinal product subject to special medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 51208
Region: Kingdom of Sweden
Marketing authorisation holder: Etypharm
Identifier:
Status: Valid (2015-07-16)
Package 1 of 2
PCID:
Description: Blister, 28 tabletter (endos)
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 28 Blister (Aluminium) (PolyVinyl Chloride) (Orientated PolyAmide) (PolyEthylene TerePhthalate) (Paper)
Containing: 1 Tablet
Manufactured Item
Dose form: Oral lyophilisate
Unit of presentation: Tablet
Ingredient
Role: Active
Substance: Buprenorphine hydrochloride
Presentation strength: 8.624 milligram(s) / 1 tablet
Reference strength: Buprenorphine 8 milligram(s) / 1 tablet
Package 2 of 2
PCID:
Description: Blister, 7 tabletter (endos)
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 28 Blister (Aluminium) (PolyVinyl Chloride) (Orientated PolyAmide) (PolyEthylene TerePhthalate) (Paper)
Containing: 1 Tablet
Manufactured Item
Dose form: Oral lyophilisate
Unit of presentation: Tablet
Ingredient
Role: Active
Substance: Buprenorphine hydrochloride
Presentation strength: 8.624 milligram(s) / 1 tablet
Reference strength: Buprenorphine 8 milligram(s) / 1 tablet
Administrable Product (1 of 1)
Dose form: Oral lyophilisate
Unit of presentation:
Route of administration:
Ingredient
Role: Active
Substance: Buprenorphine hydrochloride
Presentation strength: 8.624 milligram(s) / 1 tablet
Reference strength: Buprenorphine 8 milligram(s) / 1 tablet